World's Best Scientists 2026 revealed!
EBioMedicine
H-index 96

EBioMedicine

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 81 1439 1064 78

Additional Metrics

Number of Best Scientists*: 3215
Documents by Best Scientists*: 1794
Top 100 Ranked Scientists*: 118
SCIMAGO H-index: 136
SCIMAGO SJR: 3.591
Impact Factor: 10.8

Overview

Top Research Topics at EBioMedicine?

The journal aims to foster the development of research in Internal medicine, Cancer research, Immunology, Oncology and Virology. EBioMedicine facilitates discussions on Internal medicine that incorporate concepts from other fields like Gastroenterology and Endocrinology. Cancer cell, Cancer, Metastasis, Carcinogenesis and In vivo are some topics wherein Cancer research research discussed in the journal have an impact.

The Immunology study tackled is a key component of adjacent topics in the area of Disease. Virus is a key component of Virology research discussed in it.

  • Internal medicine (23.43%)
  • Cancer research (19.43%)
  • Immunology (15.43%)

What are the most cited papers published in the journal?

  • Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. (760 citations)
  • The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey (439 citations)
  • Cellular Senescence: A Translational Perspective. (377 citations)

Research areas of the most cited articles at EBioMedicine:

The journal articles mostly deal with topics like Internal medicine, Immunology, Cancer research, Virology and Cancer. The most cited articles facilitate discussions on Internal medicine that incorporate concepts from other fields like Gastroenterology, Endocrinology, Surgery and Oncology. The studies tackled in the published articles, which mainly focus on Immunology, apply to Disease as well.

What topics the last edition of the journal is best known for?

  • Gene
  • Internal medicine
  • Cancer

The previous edition focused in particular on these issues:

EBioMedicine explores disciplines such as Internal medicine, Immunology, Cancer research, MEDLINE and Virology. The research on Internal medicine discussed in EBioMedicine draws on the closely related field of Oncology. Immune system, Antibody, Cytokine and Vaccination are all topics related to Immunology research discussed.

EBioMedicine focuses on Cancer research but the discussions also offer insight into other areas such as Cancer and Immunotherapy. The study of Text mining and how it intertwines with concepts under Bioinformatics were explored in the presented MEDLINE research. EBioMedicine focuses on Virology but the discussions also offer insight into other areas such as Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus disease 2019 (COVID-19).

The most cited articles from the last journal are:

  • Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. (70 citations)
  • SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. (30 citations)
  • Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study. (27 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in EBioMedicine (based on the number of publications) are:

  • Rudolf Valenta (13 papers) absent at the last edition,
  • Zigang Dong (10 papers) absent at the last edition,
  • Jie Tian (10 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • Ann M. Bode (9 papers) absent at the last edition,
  • Pei Yong Shi (8 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in EBioMedicine (based on the number of publications) are:

  • Shanghai Jiao Tong University (134 papers) published 14 papers at the last edition, 11 less than at the previous edition,
  • National Institutes of Health (109 papers) published 16 papers at the last edition, 4 more than at the previous edition,
  • Harvard University (82 papers) published 9 papers at the last edition, 1 less than at the previous edition,
  • Fudan University (75 papers) published 16 papers at the last edition, 2 less than at the previous edition,
  • Sun Yat-sen University (74 papers) published 16 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.80% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 20.18% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.53% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.30% of all publications and 50.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Potential Career Opportunities in EBioMedicine Research Fields

A considerable part of the research in the field of bio-medicine is driven by a desire to improve health outcomes. By pursuing a career in research, individuals can contribute to the development of new treatments and therapies in areas such as internal medicine, immunology, cancer research, and virology, which are prominent topics in EBioMedicine. While studying for a career in research, students may opt for a variety of academic paths. A path that is often overlooked is becoming a nurse practitioner. Nurse practitioners are in high demand and have the opportunity to work in various specialty fields, including the research areas prevalent in EBioMedicine. As a nurse practitioner, one would gain a unique perspective to apply their broad clinical knowledge into their research work. For instance, if a nurse practitioner focuses on the field of oncology, they could enhance their understanding of cancer research. They could then bring a clinical perspective to cancer research studies, bridging the gap between theory and practice. For those interested in a nursing career within the state, there are numerous reputable nurse practitioner programs in New Hampshire to consider. These programs offer an excellent foundation for aspiring nurse practitioners, with curriculum that covers a wide range of health science subjects, as well as hands-on clinical experiences. Pursuing a career in the research-centric areas of health science discussed in EBioMedicine not only promises a rewarding profession but also plays an integral part in elevating the quality of healthcare and paving the way for advances in medicine.

Top Publications

  • Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?

    Sara Deleu;Kathleen Machiels;Jeroen Raes;Kristin Verbeke

    (2021)
    437 Citations
  • Vascular occlusion by neutrophil extracellular traps in COVID-19.

    Moritz Leppkes;Jasmin Knopf;Elisabeth Naschberger;Aylin Lindemann

    (2020)
    423 Citations
  • Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.

    Eun Kim;Geza Erdos;Shaohua Huang;Thomas W. Kenniston

    (2020)
    398 Citations
  • Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology

    Rossana Bussani;Edoardo Schneider;Lorena Zentilin;Chiara Collesi

    (2020)
    339 Citations
  • SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta.

    Fabio Facchetti;Mattia Bugatti;Emma Drera;Claudio Tripodo

    (2020)
    248 Citations
  • Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies

    (2022)
    235 Citations
  • Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial.

    Peter Bergman;Peter Bergman;Ola Blennow;Ola Blennow;Lotta Hansson;Lotta Hansson;Stephan Mielke;Stephan Mielke

    (2021)
    216 Citations
  • Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.

    Maria Pia Sormani;Matilde Inglese;Irene Schiavetti;Luca Carmisciano

    (2021)
    212 Citations
  • Genetics of mitochondrial diseases: Identifying mutations to help diagnosis.

    Sarah L. Stenton;Holger Prokisch

    (2020)
    210 Citations
  • Mitochondria in acute myocardial infarction and cardioprotection.

    Chrishan J.A. Ramachandra;Chrishan J.A. Ramachandra;Sauri Hernandez-Resendiz;Sauri Hernandez-Resendiz;Sauri Hernandez-Resendiz;Gustavo E. Crespo-Avilan;Gustavo E. Crespo-Avilan;Gustavo E. Crespo-Avilan;Ying-Hsi Lin;Ying-Hsi Lin

    (2020)
    202 Citations

Related Online Degrees & Career Pathways

For those interested in Medicine in the USA but seeking alternative or complementary career options, health information management and medical coding offer promising pathways. Becoming a certified professional coder can open doors to specialized roles involving medical data accuracy and billing. Certification costs and salary prospects vary, but the growing healthcare sector ensures steady demand.

The role of a medical coder salary is competitive and often increases with experience and advanced certifications. Given the precision required, those interested should consider structured training and education to build a strong foundation.

Exploring the medical billing and coding job outlook helps to understand the broader industry trends, including potential job growth and challenges such as evolving technology and regulatory changes. This knowledge assists in making informed career decisions.

Many students prefer flexible learning options like health information management schools online as they balance education with work. These programs provide practical skills relevant to healthcare administration and offer an affordable alternative for advancing careers in the medical field.

Best Scientists Contributing to This Journal

Recently Published Articles